Amerigen Pharmaceuticals and Stason Pharmaceuticals have entered into a collaboration agreement regarding the development of generic oral oncology products. Stason will use its specialized containment facilities and formulation expertise to develop and manufacture products for Amerigen to commercialize in the U.S. and other territories. Stason received an undisclosed upfront fee and is eligible for additional product-specific development milestones, plus manufacturing revenues and royalties on a...